Skip to content

Gelweave™ 732211XL55Recalls & reported problems

Vascutek Ltd · Gelweave Gelatin Impregnated Woven Vascular Prosthesis EXTRA LONG BIFURCATE · Class 2 · Implant

All models of Gelweave (47)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
1
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 05037881107660), received between Apr 23, 2020 and Dec 18, 2023 — classified as 1 death, 1 malfunction.

The most frequently reported specific device problem is “Defective Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Defective Device1
  • Infusion or Flow Problem1

Patient problems

  • Death1
  • Hematoma1
  • Hemorrhage/Blood Loss/Bleeding1
  • Insufficient Information1
  • Ischemia1
  • Respiratory Distress1
  • Thrombosis1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 18, 2023Defective Device; Defective Device

    DEVICE FAILURE/ DEFICIENCY WAS DUE TO LOOSE KNIT AT THE GRAFT BIFURCATION. BLOOD LEAKAGE AT THE BIFURCATION LEVEL. PATIENT OUTCOME: NEED TO SEW THE GRAFT HOLE WITH A 5.0 THREAD TO GET HEMOSTASIS OF THE GRAFT. THIS REPORT IS BEING SUBMITTED AS A INITIAL / FINAL FOR MFG. REPORT TO PROVIDE EVENT CLOSURE INFORMATION FOR COMP (B)(4).

    Patient problems: Insufficient Information

    MAUDE report 18343321 ↗
  • DeathApr 23, 2020Infusion or Flow Problem; Infusion or Flow Problem

    ON THE 26-MAR-20 VASCUTEK LTD. RECEIVED THE FOLLOWING INFORMATION FROM OUR DISTRIBUTOR (TERUMO (B)(4)): PATIENT UNDERWENT PROCEDURE FOR OPEN ABDOMINAL AORTIC ANEURYSM AND AORTO-BI-ILIAC BYPASS AND REIMPLANTATION BILATERAL RENAL ARTERIES (EXACT DATE UNKNOWN AT THIS TIME) THE ADDITIONAL NARRATIVE ON THE EVENT IS AS FOLLOWS: "THE PATIENT DIED ON (B)(6) 2020: HIS CONDITION WAS COMPLICATED DURING THE NIGHT OF (B)(6) 2020 WITH ISCHEMIA OF THE RIGHT LOWER LIMB AND THROMBOSIS OF THE RIGHT RENAL ARTERY WHICH JUSTIFIES A FIRST SURGICAL REINTERVENTION ON (B)(6) 2020 FOR THROMBECTOMY RIGHT RENAL AND BILATERAL EXTERNAL ILIAC, RIGHT RENAL BYPASS WITH PROSTHESIS, BILATERAL ILIOFEMORAL BYPASSES WITH PROSTHESIS, ANGIOPLASTY STENTING OF THE RIGHT SUPERFICIAL FEMORAL ARTERY AND PLACEMENT OF JJ PROBE IN THE LEFT URETER . DURING THE NIGHT OF (B)(6) 2020, THE PATIENT PRESENTED A HEMORRHAGIC SHOCK RELATED TO A HEMATOMA OF THE RIGHT PSOAS. IT THEN PROGRESSES TO MESENTERIC ISCHEMIA AND ARDS. DEATH ON (B)(6) 2020."

    Patient problems: Death; Hematoma; Hemorrhage/Blood Loss/Bleeding; Ischemia; Respiratory Distress; Thrombosis

    MAUDE report 9989505 ↗

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page